Abstract: A system for generating a path when a travel lane of a driver's vehicle is changed, may include a detector configured to recognize line information on a front side of the driver's vehicle, an input device configured to input a lane changing command of the driver's vehicle, and a controller configured to generate a lane changing path using vehicle behavior information generated based on the lane changing command and the line information and target behavior information, and to compare a time period until the driver's vehicle overlaps a line when the driver's vehicle changes the line and a time period which is set to maintain a current travel lane to control the lane changing path.

Abstract: An apparatus for automatically setting a speed of a vehicle may include a path guide device configured to obtain information related to a location of the vehicle, a type of a road corresponding to the location, and a speed limit of the road corresponding to the location and a controller configured to be electronically connected to the path guide device, wherein the controller is configured to activate an automatic setting mode for setting a setting speed for autonomous driving of the vehicle to a speed limit of a road corresponding to a current location of the vehicle, when the vehicle enters another type of road from the specified type of road in a state where the automatic setting mode is activated, release the automatic setting mode, and activate the automatic setting mode.

Abstract: A lane keeping assist method and system may include determining a driving state of a vehicle according to a state of a lane change in which an intention of a driver is reflected after a turn signal is applied, adjusting a criterion for driver override depending on an error between a driving path of the vehicle and a target path according to the driving state of the vehicle, comparing a steering torque of the driver with the adjusted criterion to determine activation or cancellation of the driver override, minimizing the driver's discomfort in the steering operation when the driver intentionally changes the lane.

Abstract: An apparatus for recognizing a driving lane of a vehicle includes a first lane attribute information extractor configured to extract front lane attribute information from a front image of the vehicle. A second lane attribute information extractor is configured to extract current position lane attribute information depending on a current position and a progress direction of the vehicle. A driving lane determiner is configured to determine a current driving lane of the vehicle depending on the front lane attribute information and the current position lane attribute information.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer, comprising (S)-(?)-benproperine or a pharmaceutically acceptable salt thereof as an active ingredient, and a method for preventing or treating cancer using the same.

Abstract: An apparatus for recognizing a driving lane of a vehicle includes a first lane attribute information extractor configured to extract front lane attribute information from a front image of the vehicle. A second lane attribute information extractor is configured to extract current position lane attribute information depending on a current position and a progress direction of the vehicle. A driving lane determiner is configured to determine a current driving lane of the vehicle depending on the front lane attribute information and the current position lane attribute information.

Abstract: The present invention relates to a novel pharmaceutical composition of benproperine derivatives for preventing and treating angiogenesis-related diseases. The benproperine derivatives and pharmaceutically acceptable salts thereof according to the present invention inhibit cancer cell migration and the angiogenesis of vascular endothelial cells, and therefore can be effectively used not only as an anticancer agent, but also as an agent for preventing and treating diseases caused by abnormal angiogenesis, such as diabetic retinopathy and corneal transplant rejection.

Abstract: The present invention relates to a novel pharmaceutical composition of benproperine derivatives for preventing and treating angiogenesis-related diseases. The benproperine derivatives and pharmaceutically acceptable salts thereof according to the present invention inhibit cancer cell migration and the angiogenesis of vascular endothelial cells, and therefore can be effectively used not only as an anticancer agent, but also as an agent for preventing and treating diseases caused by abnormal angiogenesis, such as diabetic retinopathy and corneal transplant rejection.

Abstract: Disclosed herein are novel obovatol derivatives represented by Chemical Formula 1, and pharmaceutically acceptable salts thereof. Having the ability to inhibit the growth of cancer cells and induce apoptosis in cancer cells, the derivatives or pharmaceutically acceptable salts thereof are useful in the prevention and treatment of cancer and in the suppression of cancer metastasis. Also, a method for preparing the derivatives, and pharmaceutical compositions comprising the derivatives as active ingredients are disclosed. wherein R1, R2 and R3 are as defined in the specification.

Abstract: Disclosed herein are a novel cinnamaldehyde compound represented by Chemical Formula 1 or pharmaceutically acceptable salts thereof. The cinnamaldehyde compound has improved solubility in water and has inhibitory effects on the growth of cancer cells because it induces cell cycle arrest and cell death. Also disclosed are a method of preparing the cinnamaldehyde compound and an anticancer composition including the compound of Chemical Formula 1.

Abstract: Disclosed herein are a novel cinnamaldehyde compound represented by Chemical Formula 1 or pharmaceutically acceptable salts thereof. The cinnamaldehyde compound has improved solubility in water and has inhibitory effects on the growth of cancer cells because it induces cell cycle arrest and cell death. Also disclosed are a method of preparing the cinnamaldehyde compound and an anticancer composition including the compound of Chemical Formula 1.

Abstract: The present invention relates to a composition for the prevention and treatment of inflammatory disease containing the extracts of Magnolia obovata or fractions thereof as an active ingredient, more precisely, a composition for the prevention and treatment of inflammatory disease containing the extracts of Magnolia obovata fruits and floral buds extracted with alcohol or alcohol aqueous solution as a solvent and active fractions isolated from the same. The extracts and fractions of the present invention inhibit lipopolysaccharide (LPS) induced nitric oxide (NO) generation significantly, have anti-inflammation activity and low cytotoxicity, and contain all of major effective components isolated from Magnolia obovata such as obovatol, honokiol and magnolol, so that they can be effectively used for the prevention and treatment of inflammatory disease.

Abstract: The present invention relates to a composition containing the extracts of Magnolia obovata Thunberg or fractions thereof for the prevention and treatment of cancer and for the inhibition of metastasis. Particularly, the extracts of Magnolia obovata Thunberg fruits and floral buds extracted with water, alcohol or a mixture thereof as a solvent and fractions isolated from the same inhibit metastasis by inhibiting migration of those cells over-expressing PRL-3 which plays an important role in cancer cell growth and migration and at the same time induce apoptosis of cancer cells, so that they can be effectively used as a composition for the prevention and treatment of cancer or a composition for the inhibition of metastasis.

Abstract: Disclosed herein are novel obovatol derivatives represented by Chemical Formula 1, and pharmaceutically acceptable salts thereof. Having the ability to inhibit the growth of cancer cells and induce apoptosis in cancer cells, the derivatives or pharmaceutically acceptable salts thereof are useful in the prevention and treatment of cancer and in the suppression of cancer metastasis. Also, a method for preparing the derivatives, and pharmaceutical compositions comprising the derivatives as active ingredients are disclosed. wherein R1,R2 and R3 are as defined in the specification.